Oslo - Delayed Quote NOK
Lytix Biopharma AS (LYTIX.OL)
7.60
-0.10
(-1.30%)
At close: May 16 at 4:25:26 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 1.7M | 90.3M |
| Low Estimate | -- | -- | 1.7M | 90.3M |
| High Estimate | -- | -- | 1.7M | 90.3M |
| Year Ago Sales | -- | -- | -- | 1.7M |
| Sales Growth (year/est) | -- | -- | -- | 5,211.76% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LYTIX.OL | -- | -- | -- | -- |
| S&P 500 | 13.21% | 2.76% | 7.83% | 13.78% |
Related Tickers
CRNA.OL Circio Holding ASA
0.6270
-4.27%
PCIB.OL PCI Biotech Holding ASA
1.7600
-5.38%
BGBIO.OL BerGenBio ASA
1.7500
+2.58%
ONCIN.OL Oncoinvent ASA
1.6060
+1.01%
ZLNA.OL Zelluna ASA
13.75
-1.06%
ABS.OL Arctic Bioscience AS
3.8500
+4.05%
FLUI.ST Fluicell AB (publ)
10.40
+1.96%
AZT.OL ArcticZymes Technologies ASA
16.60
+0.91%
TRMED.OL Thor Medical ASA
2.6050
+4.83%
VRCA Verrica Pharmaceuticals Inc.
0.6623
+3.19%